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Abstract
Background
The in-hospital treatment of patients with traumatic brain injury (TBI) is considered to be
expensive, especially in patients with severe TBI (s-TBI). To improve future treatment deci-
sion-making, resource allocation and research initiatives, this study reviewed the in-hospital
costs for patients with s-TBI and the quality of study methodology.
Methods
A systematic search was performed using the following databases: PubMed, MEDLINE,
Embase, Web of Science, Cochrane library, CENTRAL, Emcare, PsychINFO, Academic
Search Premier and Google Scholar. Articles published before August 2018 reporting in-
hospital acute care costs for patients with s-TBI were included. Quality was assessed by
using a 19-item checklist based on the CHEERS statement.
Results
Twenty-five out of 2372 articles were included. In-hospital costs per patient were generally
high and ranged from $2,130 to $401,808. Variation between study results was primarily
caused by methodological heterogeneity and variable patient and treatment characteristics.
The quality assessment showed variable study quality with a mean total score of 71%
(range 48% - 96%). Especially items concerning cost data scored poorly (49%) because
data source, cost calculation methodology and outcome reporting were regularly unmen-
tioned or inadequately reported.
Conclusions
Healthcare consumption and in-hospital costs for patients with s-TBI were high and varied
widely between studies. Costs were primarily driven by the length of stay and surgical inter-
vention and increased with higher TBI severity. However, drawing firm conclusions on the
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actual in-hospital costs of patients sustaining s-TBI was complicated due to variation and
inadequate quality of the included studies. Future economic evaluations should focus on the
long-term cost-effectiveness of treatment strategies and use guideline recommendations
and common data elements to improve study quality.
Introduction
Healthcare expenditures are rising worldwide and endanger the affordability of national
healthcare systems. [1, 2] To secure their future existence, a thoughtful and righteous distribu-
tion of limited resources is essential. Policy makers and healthcare professionals are therefore
increasingly expected to study the effectiveness of treatments and its associated costs. [3, 4]
After all, the input from high quality cost research is required to make healthcare systems effi-
cient and to achieve the highest quality of care for the lowest costs. [5]
Also in the field of traumatic brain injury (TBI), with an estimated total global annual bur-
den of US$ 400 billion, research efforts are increasingly conducted towards cost- effectiveness.
[6–10] After sustaining a TBI, in-hospital treatment is frequently required and generally associ-
ated with high costs. [11–14] In the USA, the 2010 TBI-related in-hospital charges totalled US$
21.4 billion. [15] In-hospital costs after TBI are increasing annually and represent a substantial
part of the total financial TBI burden. [15] The highest individual costs in TBI patients are gen-
erally seen in patients with severe TBI (s-TBI). [16] These patients also have the longest hospital
or intensive care unit (ICU) length of stay (LOS) and the highest number of (neuro)surgical and
medical interventions. [16–18] Despite their substantial healthcare consumption, these vulnera-
ble patients show high rates of mortality and unfavourable outcome. Especially for these
patients with poor outcome at high costs, a critical appraisal of treatment costs-effectiveness is
essential to avoid ineffective expenditures and improve treatment decision-making. [19–22]
Two recent reviews on healthcare costs after TBI have reported about the considerable vari-
ation in healthcare costs after TBI between different studies and about the insufficient quality
of the available cost studies.[7, 10] These reviews however were mainly focussed on the meth-
odological quality of economic evaluations and therefore did not report the actual in-hospital
costs. Insight into in-hospital costs and important components of the costs, such as healthcare
utilization and other factors that drive these costs were not provided. This is important infor-
mation for physicians and policymakers, because this information is needed for decision-mak-
ing and for correct allocation of resources.
In this systematic review, we have therefore focussed on: (1) providing a detailed insight in
the reported in-hospital costs for patients with s-TBI and (2) assessing the (quality of) study
methodology.
Methods
This systematic review was conducted according to the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) guidelines. [23] (S1 Table) The study protocol was
registered in the PROSPERO International Prospective Register of Systematic Review with
registration number CRD42018081131.
Literature search
A final systematic literature search was performed on the 8th of August 2018 using the follow-
ing databases: PubMed, MEDLINE, Embase, Web of Science, Cochrane library, CENTRAL,
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Emcare, PsychINFO, Academic Search Premier and Google Scholar. The search strategy was
developed and conducted with the assistance of a trained clinical librarian. All relevant infor-
mation on the literature search can be found in S1 Appendix. In addition to the search, the ref-
erence lists of all included articles were manually checked for additional relevant studies.
Inclusion/Exclusion criteria
Studies were included when the in-hospital costs or in-hospital charges of a cohort of>10
patients with s-TBI were reported. Because the appellation “severe TBI” encompassed a range
of brain injuries considered to be too varied for appropriate comparison the two most widely
used classifications for s-TBI were applied: Glasgow Coma Scale (GCS)�8 and/or Abbreviated
Injury Scale (AIS)�4. [24–26] We excluded reviews, commentaries, editorials, conference and
meeting abstracts, unpublished data, non-English studies and studies that could not be found
or retrieved in full text. Studies were also excluded when in-hospital costs related to acute care
were not distinguishable from other costs like indirect non-healthcare related costs (e.g. loss of
productivity), (in-hospital) rehabilitation or long-term costs. There were no restrictions on
publication date or patient characteristics.
Article selection and data extraction
First, duplicates, non-English and unretrievable records were excluded. Second, two reviewers
(JD,MD) independently screened the titles and abstracts of the remaining studies and selected
all potential eligible studies. Full-texts were independently reviewed by the same researchers
and studies were included according to the above mentioned criteria. During the process, all
disagreements were resolved through discussion until consensus or after consulting a third
researcher (RO). Data extraction was performed in duplicate using pre-created data extraction
sheets. Extracted data was then discussed and combined. Variables that were collected
included: study details, study population, definition of TBI (including severity), healthcare
consumption, details of costs research methodology and cost outcome results.
Quality assessment
A 19-item checklist was used to assure an accurate quality assessment for the evaluation of in-
hospital costs following s-TBI. The checklist was based on the CHEERS statement, which is
developed to improve the reporting on economic evaluations. [27–30] We slightly adjusted the
items from the CHEERS statement by specifying items like ‘target population and subgroups’
in clear definition of illness and TBI severity, because this was deemed necessary for proper
interpretation of study results. Also we intentionally left out items like cost perspective, time
horizon and discounting costs since these were considered not relevant for short term in-hos-
pital costs. The final checklist covers items in the areas of study details, population, clinical
data, cost data and study methodology. All relevant details can be found in S2 Appendix.
The quality assessment was independently performed by three reviewers (JD, MD, RO).
Disagreements were reassessed and discussed in several meetings until consensus was reached.
All items were scored according to a predefined scoring manual that included four options:
yes (1), suboptimal (0.5), no (0) and not applicable (N/A). A double weight was assigned to
several items that were considered to be particularly important in calculating and reporting in-
hospital costs. Final scores represented study quality and were presented as a percentage of the
maximum score per study. Scores per item and item category were also calculated. All items
that were not applicable were excluded from score calculation. When studies used a statistical
model, items were scored considering the clear use and description of the model input param-
eters and sources.
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Outcome
All relevant data was reported in a descriptive manner. In line with the inclusion criteria,
patients were included from three different severity groups as they were reported in the
included studies (GCS�8, AIS�4, AIS�5). These subgroups were also used in the text and fig-
ures. In one figure, hospital LOS was presented by using black indicators (■) and ICU LOS by
white indicators (□). A clear distinction between hospital costs and hospital charges, when
known, was made by using black and white indicators respectively. In-text, both the reported
hospital charges and hospital costs were presented as in-hospital costs. The Gross Domestic
Product (GDP) per capita of the study country was included as reference value, to improve
comparability between the reported costs. The reference year that was used, corresponded
with the currency year. [31] All costs, including GDP per capita, were converted to US dollars
(2015) using the CCEMG–EPPI-Centre Cost Converter. [32] This web-based tool utilizes
Gross Domestic Product deflator index values and Purchasing Power Parities conversion rates
provided by the International Monetary Fund. [33] In case a reference year was not provided
we used the last year in which patients were included or, when unknown, the year of publica-
tion. Figures were designed with GraphPad Prism version 7.0.2.
Results
Literature search and study selection
The systematic literature search identified 2372 studies (Fig 1). First, a total of 283 duplicate,
non-English or unfindable studies were removed. The remaining 2089 studies were screened
on title and abstract, resulting in 204 studies considered eligible for full-text assessment. Stud-
ies were excluded because; (1) they did not include a s-TBI cohort defined by a GCS�8 and/or
AIS�4 (N = 134), (2) they did not report hospital costs for patients with s-TBI (N = 28) or (3)
in-hospital acute care costs were not distinguishable from other costs (N = 13). No additional
studies were identified through the reference check. Ultimately, 25 articles were included in
this systematic review.
Study characteristics
The main study characteristics can be found in Table 1. Twelve studies were published after
2010, nine between 2000 and 2019, and four before 2000. Cohort size ranged from 20 to 7774
patients. [34, 35] Nineteen studies were conducted in high income countries of which sixteen
in the USA. The majority of studies focused on adult patients, while some studies focused on
paediatric [34, 36–38] and elderly patients. [35, 39] Nineteen studies (76%) had cost research
in TBI patients as a research objective. TBI was often only defined by mentioning “TBI” or
“head injury” (N = 9). Six studies provided only little additional information and nine studies
used ICD (N = 8) and/or AIS codes (N = 2). Severity was defined by GCS (68%), by AIS (28%)
or both (4%). The used GCS was obtained at admission (n = 7), the emergency department
(n = 3) and the time remained unknown in 5 studies. A retrospective study design was used in
60% [35–37, 39–50], followed by a prospective design (16%) [34, 51–53] or a combination of
both (12%). [54–56] Three studies used a statistical model. [38, 57, 58]
Quality of study methodology
The results of the quality assessment are presented in detail in S2 Table. Study quality was vari-
able with an average total score of 71% and a range of 48% to 96%. Seven studies achieved a
score above 80%, representing “high quality”. [36, 38, 39, 47, 50, 53, 58] Especially items in the
‘cost data’ subgroup scored poorly (49%). All but one study mentioned their cost data source,
Review on in hospital costs after severe traumatic brain injury
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but a clear description was missing in 24%. Also, the design and methods of costs analysis
were not mentioned in 36% and were unclear in another 16%. Eleven studies properly assessed
hospital activity data but only three studies appropriately valued and reported unit costs. Hos-
pital costs were disaggregated in 20% of studies and in 52% charges were reported instead of
costs. Major assumptions were tested in a sensitivity analysis in only 16% and a reference year
was missing in 14% of the studies. The subgroups ‘study details’, ‘population’ and ‘methodol-
ogy’ had the highest scores (100%, 87% and 78%). There were infrequent statements on source
of funding and conflicts of interest, unsatisfying TBI definitions and inadequate evaluation of
study findings.
Hospital costs & healthcare consumption
The median reported in-hospital costs per patient were $55,267 (mean $87,634) and ranged
from $2,130 to $401,808 (Fig 2). The lowest costs were seen in studies from China, Pakistan
and Malaysia ($2,130 to 10,356) [35, 50, 51, 53, 56] and in a subgroup of paediatric non-survi-
vors in the USA ($7,081). [37] The highest in-hospital costs ($258,790 to $401,808) were found
in three studies describing different patient cohorts from the USA. [40, 52, 55] The in-hospital
costs as percentage of the GDP per capita (median 128%, mean 234%) were highly variable
Fig 1. Flow chart of the article selection process.
https://doi.org/10.1371/journal.pone.0216743.g001
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and ranged from 15% to 990%. [37, 56] Mean percentages were not significantly different
between high and lower income countries and between charges and costs (204% vs. 333% and
289% vs. 202%).
Fourteen studies reported LOS for patients with s-TBI, also showing major variation (Fig
3). [35, 36, 38, 40, 43, 45–47, 50–52, 54–56] ICU LOS ranged from 7.9 to 25.8 days (GCS�8)
[40, 43], 6 to 19 days (AIS�4) and 6 to 21 days (AIS�5). [35, 47] Hospital LOS ranged from 10
to 36.8 days (GCS�8) [38, 54], 10 to 26.1 days (AIS�4) [47, 52] and 11 to 17.5 days (AIS�5).
[46, 47]
Some studies reported costs related to acute care to be 46% to 67% of total hospitalization
costs, while inpatient rehabilitation costs accounted for 26% to 41%. [41, 42, 54, 57] Various
studies found that costs related to hospital LOS and ICU LOS were the main drivers of hospital
costs. [36, 38, 39, 47, 50, 53] Costs related to ICU care comprised the biggest part of total hospi-
tal costs (51–79%), followed by costs related to ward admission (12–38%), surgery (4–8%) and
imaging/laboratory (<3%). [36, 38, 47] Physician charges were reported to be 12% to 20% of
total costs. [39, 41] One study included the salary of paramedics and found salary to be the
most important contributor (71–79%) to total provider costs. [39, 41, 51] The majority of
costs, up to 90%, were made in the first year after trauma and were generally associated with
TBI-related hospitalization costs. [41, 48, 57] The share of acute hospital services (18%) and
rehabilitation (27%) on total costs decreased when a long-term follow-up period was used.
[52]
Several studies provided some additional information on clinical factors that were associ-
ated with reported costs. A higher TBI severity was generally related with an increased LOS
and costs. [34, 35, 37–39, 41, 42, 46–50, 53, 54] Even among patients with a s-TBI, patients
with a GCS3-5 or AIS = 5 were more expensive than patients with a GCS6-8 or AIS = 4, respec-
tively. [34, 35, 39, 40, 46, 47, 54] A higher overall injury severity was also related with higher
costs. [39, 47, 53] Male gender was linked with higher costs [35, 39, 53] and two studies men-
tioned that a higher age was more expensive. [47, 50] Costs were also influenced by trauma
mechanism and were higher for motor vehicle accidents and gunshot wounds and lower after
an assault to the head. [34, 35, 39, 46, 53, 54] The use of surgical intervention, intracranial pres-
sure monitoring or mannitol were all related to longer LOS and higher costs. [37, 38, 45, 53,
54] Also, the introduction of guidelines and evidence based medicine protocols appeared to
increase LOS and hospital costs [43, 55], while improvement of guideline adherence did not
change ICU and hospital costs in another study. [36] Three studies related costs to outcome
and found lower costs for patients that died or made a good recovery. [37, 53, 58]
Discussion
This systematic review demonstrates that the in-hospital costs related to acute care for patients
with s-TBI are generally high and increase with severity of TBI and overall severity of the
injury. Both healthcare consumption and in-hospital costs are highly variable between studies
and associated with factors such as mechanism of injury and treatment strategy.
Three previous reviews on costs after TBI were generally in line with our results, but results
were difficult to compare with the present review due to differences in study objectives and
substantial variation between the included studies that was mainly caused by differing method-
ological and clinical characteristics. [7, 59, 60] Elaborating on these reviews, we specifically
investigated the in-hospital costs related to acute care for patients with s-TBI aiming to reduce
variation and improve study comparability. Methodological and clinical heterogeneity
remained present, likely contributing to the variation in in-hospital costs between studies. The
highest in-hospital costs were found in studies from the USA that reported charges instead of
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Fig 2. In-hospital costs and in-hospital charges of a patient with s-TBI. Black indicators represent in hospital costs,
while white indicators represent in-hospital charges. A bigger indicator size, represents a bigger study cohort size. • �:
Paediatric ♦ ^: Adult ■ □: Elderly.
https://doi.org/10.1371/journal.pone.0216743.g002
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Fig 3. ICU and hospital length of stay of a patient with s-TBI. Black indicators represent hospital length of stay,
while white indicators represent ICU length of stay. A bigger indicator size, represents a bigger study cohort size. • �:
Paediatric ♦ ^: Adult ■ □: Elderly.
https://doi.org/10.1371/journal.pone.0216743.g003
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costs. Because hospital charges are not actual costs and usually higher than hospital costs, this
increased total amounts. Charges are also often non-transparent and the resultant of deals
between hospitals and insurance companies or other stakeholders. It is therefore preferred to
calculate and report total costs by using healthcare utilization with its corresponding unit
costs. Also, USA healthcare expenditures are twice as high as expenditures in other high-
income countries. [2, 61] While healthcare utilization patterns were rather similar between
high-income countries, the higher expenditures were especially caused by higher prices of
labour, goods, pharmaceuticals and administrative costs. [2, 62] Large international differences
were also seen between European countries when assessing injury related hospitalization costs.
[63] Likewise, the lowest in-hospital costs were found in studies from lower-income countries,
which is also in accordance with literature. [64] These absolute costs are lower because of
lower prices, lower treatment intensity and higher mortality rates with associated lower
resource utilization. [64, 65] In-hospital costs reported as percentage of GDP per capita were
however not significantly different between high and low income countries, suggesting a simi-
lar financial impact for patients. Differences in costs might also be caused by hospital associ-
ated factors (e.g. level of trauma center, volume, treatment protocols) and by the major
epidemiological differences of trauma populations between countries. [6] The different time-
frames included in this review could also contribute to variation, since treatment strategies
have changed over time and healthcare costs have been increasing globally over the years. [15,
64, 66] Comparing in-hospital costs from different healthcare systems in different timeframes
is therefore problematic.
As in literature, the identified in-hospital costs increase with higher TBI severity. [9, 16, 60,
67] Costs increase because they primarily consist of costs related to LOS and surgical interven-
tions and because the utilization of both is higher in more severely injured TBI patients. [68–
71] After all, healthcare expenses are equal to utilization multiplied by associated prices. [62]
Also in other studies, physician charges are another important contributor to in-hospital costs.
[2, 72] Length of stay results and its variability seemed to be in accordance with literature, but
were difficult to compare due to this variation. [68, 69] Like in previous research, extracranial
injuries and overall injury severity contributed to higher healthcare consumption and in-hos-
pital costs. [67, 69, 73–75] Distinguishing costs that are related to TBI or associated extracra-
nial injuries is nearly impossible. Therefore, four studies explicitly investigated patients with
isolated-TBI. [44, 51, 53, 56] Motor vehicle accidents and gunshot wounds were reported to be
related to higher costs, most likely because of higher injury severity and accompanying extra-
cranial injuries. Although a higher age is often considered to be more expensive, only few stud-
ies mentioned this and comparison between the age groups did not show obvious differences
in LOS or in-hospital costs. [15, 63, 67, 73]
Hospital and acute care costs were reported to be important constituents of total costs fol-
lowed by in-patient rehabilitation. However, the limitations of a short follow-up period have
been recognized before. [7] Although the in-hospital costs are obviously an important part,
post-discharge rehabilitation and other long term care costs are also major contributors to the
total costs after TBI. [12] When including the enormous long-term or lifetime costs and the
loss of productivity, the share of in-hospital costs on the total burden significantly decreases.
[12, 14, 76] A long-term follow up period would provide a better overview for two reasons.
First, the assessment of patient outcome will be more accurate, because health problems might
persist, improve or deteriorate several years after trauma. [77, 78] Second, the cost analysis will
be more comprehensive, since a changing health situation influences healthcare consumption
and productivity for both patients and relatives. Therefore, especially for establishing the cost-
effectiveness of treatments, a long-term follow-up should be included.
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The identified most important reasons for (outcome) variation were probably all caused by
different study objectives. Study objectives determined study methodology and consequently
also the studied participants, interventions and outcome. Although most study objectives
included costs research, the major differences between them likely caused the aforementioned
methodological and clinical heterogeneity. Heterogeneity has earlier been reported for TBI
cost studies and complicates study comparison and outcome interpretation. [7, 10, 59, 60] Het-
erogeneity is not limited to TBI cost research, but is very common in general TBI research and
likewise complicates comparability, generalizability and interpretation of other studies. [79–
82]
Study quality also influenced interpretation of study results, since poor methodological
quality compromises quality and therefore value of data. Two recent reviews specifically
assessed the methodological quality of TBI cost evaluation studies and identified important
limitations regarding the adherence to the methodological principles of economic evaluations.
[7, 10] More specifically, these limitations include not reporting all relevant costs on a long-
term or lifetime horizon, not discounting future costs, not performing incremental analysis of
cost-effectiveness and applying sensitivity analysis. Our quality assessment found variable and
overall inadequate study quality. Only few studies were considered high quality and especially
items concerning the calculation and reporting of costs scored poorly. Cost results were often
provided without relevant context. A description of costs analysis methods, required to under-
stand and interpret the results, was frequently missing. Studies also rarely calculated in-hospi-
tal costs by transparently multiplying healthcare consumption with associated unit costs.
Almost no study reported the highly informative and important disaggregated costs. Even ref-
erence years were missing in several studies. Because several studies did not focus on reporting
costs after TBI, they might have scored low on our quality assessment, despite appropriately
investigating their specific study objectives.
Strengths and limitations
This systematic review benefits from an extensive literature search in multiple databases and
strict inclusion criteria, which improve study comparability and interpretation of results. The
PRISMA guidelines were used during the review process and the quality assessment made use
of a checklist that was based on the CHEERS statement and allowed the critical appraisal of the
included articles. Although the assignment of scores is partly subjective, our experiences
regarding the quality assessment using this checklist were positive. In addition, this is by our
knowledge, the first detailed overview of in-hospital costs in patients with s-TBI.
This study also has several limitations. The article selection criteria resulted in the exclusion
of some patients, that were severely injured but lacked the required severity classification.
Also, regarding in-hospital costs, studies were excluded that not clearly distinguished acute
care in-hospital costs from rehabilitation costs, indirect costs or other non in-hospital costs.
Data from these patients could have contributed to our results, but the introduction of addi-
tional methodological and clinical heterogeneity would have compromised comparability and
interpretation of study results. In addition, the used TBI severity criteria have their limitations.
The GCS has been criticized for its general applicability although it shows adequate reliability
in a recent review. [24, 83] A patient can be scored ‘false-low’ due to intubation and sedation
overestimating injury severity, while the severity of patients who quickly deteriorate after
admission will be underestimated. Also, a decreased GCS is not always caused by TBI and
could also be caused by extracranial injury alone. [84] Last, patients could be at the lower or
the higher end of the spectrum within the GCS 3–8 group. This could have substantial impact
on study results, because severity is related to costs. Regarding AIS, the classification system
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changed over time and the 2005 version codes similar injuries with a lower severity score com-
pared to the 1998 version. [85] Also, some researchers suggest using AIS�5 as severe, instead
of AIS�4. [86] Despite this, using both criteria is very relevant because they are the most
widely used criteria for s-TBI. [24] Limiting the selection to patients with s-TBI improves com-
parability, but fails to assess the financial burden caused by minor and/or moderate TBI.
Although individual costs are lower for these injuries, the total burden on society is much
higher because of their more frequent occurrence. [16] Although the distinction is clearly
made throughout, including hospital charges and hospital costs may have compromised com-
parability of study results. Since both are frequently reported, it did however make a compre-
hensive review of in-hospital expenses possible and points out the difficulty of cost research.
Last, the focus on in-hospital costs, dramatically underestimated the total financial burden
caused by s-TBI. [12, 14, 76]
Future research
Because a righteous and ethical distribution of limited healthcare resources is essential to
secure the future existence of successful healthcare systems around the world, policymakers
increasingly request high quality evidence regarding the cost effectiveness of treatments. [3]
To improve the future quality of TBI cost research, investigators should equalize methodologi-
cal and clinical heterogeneity by using specific methodological guidelines and common data
elements. [27, 87] As seen in this systematic review, one of the biggest challenges in TBI cost
research is heterogeneity. Checklists could be helpful, but the development of international
guidelines on economical evaluations for TBI patients is preferred. Patient outcome should be
investigated along with the financial burden of treatments. Therefore, cost-effectiveness analy-
sis should be included in upcoming trials investigating TBI treatment strategies. Patients from
all ages should be investigated because all are confronted with the consequences of TBI.
Because TBI related consequences and associated costs are variable over time, economic evalu-
ations should include a long-term or even lifetime horizon. [6] All associated costs adding to
the total burden on society, like indirect costs and loss of productivity, should be included to
accurately map expenditures. Also, health and financial implications for family and proxies
deserve investigation. Last, the use of accurate cost calculation methods using exact healthcare
consumption and cost price data could further improve the accuracy of cost calculations and
thus outcome results. [88, 89]
Conclusions
We conclude that healthcare consumption and in-hospital costs for patients with s-TBI are
generally high. In-hospital costs mostly consist of costs related to LOS and surgical interven-
tions. The major variation of study results is primarily caused by methodological and clinical
heterogeneity. Study quality was variable but often inadequate and especially items considered
important in calculation and reporting of in-hospital costs scored poorly. High quality future
economic evaluations could guide physicians and policy-maker in improving clinical deci-
sion-making and resource allocation. Studies should therefore focus on the long-term cost-
effectiveness of treatments and improve both study quality and equality by using guidelines
and common data elements.
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